close

NxStage Medical, Inc., a medical device company, engages in the development, manufacture, and marketing of products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures in the United States. The company's primary product includes NxStage System One, a portable hemodialysis system, which is designed to provide hemodialysis therapy. It also sells needles, blood tubing, and other extracorporeal products to dialysis centers for the treatment of end-stage renal disease. NxStage Medical, Inc. offers its products primarily to dialysis clinics, as well as other hospitals that treat acute kidney failure and fluid overload. The company, formerly known as QB Medical, Inc., was founded in 1998 and is headquartered in Lawrence, Massachusetts.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	17.87
Volume	600506
Volume Avg	620177
52 Week High	24.85
52 Week Low	15.42
PE	N/A
PE (group average)	39
EPS Year	-0.40
EPS change Q/Q	-15.38%
EPS change Q/Q Yr ago	-42.11%
EPS change Q/Q next Q est	-22.22%
EPS change Y/Y	-50%
REV change Q/Q	1.61%
REV change Q/Q Yr ago	25.25%
EPS next Q est	-0.09
EPS next Y est	-0.06
Divident Annual	0.00
Dividend Yield	0%